In honor of Pride Month, the Columbia Gender & Sexuality Program offers a family-friendly guide to support LGBTQIA+ youth and caregivers and a list of events taking place across the city.
Rep. Adriano Espaillat (NY-13) and Rep. Mike Lawler (NY-17) have introduced the Community Mental Wellness Worker Training Act to increase the availability of mental health services to the underserved.
Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Columbia psychologist Erin K. Engle discusses the signs that indicate the time is right to stop therapy and questions patients should ask themselves before moving on.
Neuronal branches become tangled in mice lacking Pcdh genes, leading to signs of depression or sensory deficits when specific genes are absent, studies find.
Illicit cannabis use and cannabis use disorders increased at a greater rate in states that passed medical marijuana laws than in other states, a new study finds.
A breakdown in the synchronized behavior of some neurons may produce schizophrenia symptoms, according to a new study of a mouse model of the disorder.
Columbia University and Weill Cornell announce Takao Hensch, PhD, as this year's recipient of the Mortimer D. Sackler, MD Prize, which recognizes leaders in developmental psychobiology.
American adults who survive deliberate self-harm—particularly with a firearm—are at increased risk of suicide in the short term, according to a new study from Columbia University.
Columbia researchers have found that giving a small dose of ketamine one week before a psychologically traumatic event may help prevent post-traumatic stress disorder.
The Chapman Perelman Foundation has contributed $1 million to Columbia Psychiatry to expand an initiative that provides mental health services to victims of domestic violence.
Among pregnant women, the prevalence of past-month marijuana use increased from 2.4 percent in 2002 to 3.9 percent in 2014, researchers from Columbia Psychiatry found.
Columbia research finds that people with schizophrenia who have difficulty hearing subtle changes in pitch may be helped with auditory training and a drug targeting NMDA receptors.